DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Outcome Analysis of the Oxford Partial Knee Arthroplasty

Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Knee Arthroplasty

Intervention: Oxford Partial Knee (Device)

Phase: N/A

Status: Recruiting

Sponsored by: Biomet, Inc.

Summary

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Clinical Details

Official title: Outcome Analysis of the Oxford Partial Knee Arthroplasty

Study design: Treatment, Open Label, Single Group Assignment, Safety/Efficacy Study

Primary outcome: WOMAC, SF12, oxford Knee,KSCRS

Secondary outcome: Length of Hospital Stay

Detailed description: Utilization of systematic outcome measurements and specific designated time frames to monitor patient satisfactions will assist in analysing this type of prosthesis and the post operative period. Data collected will be added to the compiled information from previous studies in relation to the Oxford knee.

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patient Suitable for Knee Replacement

Exclusion Criteria:

Locations and Contacts

Dartmouth General Hospital, Dartmouth, Canada; Recruiting
Vikram Venugopal, MD, Phone: (902) 469- 9667
Additional Information

Starting date: April 2003
Ending date: April 2010
Last updated: September 24, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012